(Q53420712)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21667120%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

title

A prognostic model for lymph node-negative breast cancer patients based on the integration of proliferation and immunity (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21667120%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

0 references

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21667120%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

author name string

Ensel Oh

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21667120%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Yoon-La Choi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21667120%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Taesung Park

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21667120%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Seungyeoun Lee

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21667120%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Seok Jin Nam

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21667120%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

language of work or name

English

0 references

publication date

11 June 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21667120%20AND%20SRC:MED&resulttype=core&format=json

Breast Cancer Research and Treatment

4 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21667120%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

volume

132

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21667120%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21667120%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

page(s)

499-509

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21667120%20AND%20SRC:MED&resulttype=core&format=json

Gene expression signature of fibroblast serum response predicts human cancer progression: similarities between tumors and wounds

4 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1626-8

A gene-expression signature as a predictor of survival in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1626-8

Gene expression profiling predicts clinical outcome of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1626-8

Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1626-8

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1626-8

Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1626-8

Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1626-8

An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1626-8

Oncogenic pathway signatures in human cancers as a guide to targeted therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1626-8

A consensus prognostic gene expression classifier for ER positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1626-8

Strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the TRANSBIG multicenter independent validation series

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1626-8

Development of the 21-gene assay and its application in clinical practice and clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1626-8

Clinical application of the 70-gene profile: the MINDACT trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1626-8

Outcome signature genes in breast cancer: is there a unique set?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1626-8

Effects of sample size on robustness and prediction accuracy of a prognostic gene signature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1626-8

Prediction of breast cancer metastasis by genomic profiling: where do we stand?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1626-8

Thousands of samples are needed to generate a robust gene list for predicting outcome in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1626-8

Pooling breast cancer datasets has a synergetic effect on classification performance and improves signature stability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1626-8

Can survival prediction be improved by merging gene expression data sets?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1626-8

Concordance among gene-expression-based predictors for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1626-8

A comprehensive analysis of prognostic signatures reveals the high predictive capacity of the proliferation, immune response and RNA splicing modules in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1626-8

Pathway analysis of gene signatures predicting metastasis of node-negative primary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1626-8

Gene expression meta-analysis identifies metastatic pathways and transcription factors in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1626-8

Definition of clinically distinct molecular subtypes in estrogen receptor-positive breast carcinomas through genomic grade

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1626-8

Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1626-8

The 76-gene signature defines high-risk patients that benefit from adjuvant tamoxifen therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1626-8

Genomic index of sensitivity to endocrine therapy for breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1626-8

Evolving gene/transcript definitions significantly alter the interpretation of GeneChip data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1626-8

Summaries of Affymetrix GeneChip probe level data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1626-8

Significance analysis of microarrays applied to the ionizing radiation response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1626-8

Fundamentals of survival data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1626-8

A new look at the statistical model identification

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1626-8

Estrogen receptor alpha signaling in inflammatory leukocytes is dispensable for 17beta-estradiol-mediated inhibition of experimental autoimmune encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1626-8

Coordinates in the universe of node-negative breast cancer revisited.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1626-8

Effects of infiltrating lymphocytes and estrogen receptor on gene expression and prognosis in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1626-8

Stromal gene expression predicts clinical outcome in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1626-8

Gene expression profiling of the tumor microenvironment during breast cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1626-8

A test of several parametric statistical models for estimating success rate in the treatment of carcinoma cervix uteri

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1626-8

Is breast cancer a curable disease? A study of 14,731 women with breast cancer from the Cancer Registry of Norway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1626-8

Long-term survival rates of laryngeal cancer patients treated by radiation and surgery, radiation alone, and surgery alone: studied by lognormal and Kaplan-Meier survival methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1626-8

Model-based prediction of phase III overall survival in colorectal cancer on the basis of phase II tumor dynamics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1626-8

Genomic signatures to guide the use of chemotherapeutics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1626-8

Validation of gene signatures that predict the response of breast cancer to neoadjuvant chemotherapy: a substudy of the EORTC 10994/BIG 00-01 clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1626-8

A genomic strategy to refine prognosis in early-stage non-small-cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1626-8

Pharmacogenomic strategies provide a rational approach to the treatment of cisplatin-resistant patients with advanced cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1626-8

10.1007/S10549-011-1626-8

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21667120%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

1 reference